• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 29-08-2025: Press Release

    29-08-2025 | 10:49 am

    Zydus Lifesciences' subsidiary announced positive Phase 3 trial results for Saroglitazar in Primary Biliary Cholangitis. The trial met key endpoints, showing efficacy and good tolerability. The company plans a U.S. regulatory submission in Q1 2026 for this potential new treatment.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited